Head-to-head · Cost-Efficiency Index
Better U Care vs Harbor
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Better U Care
Cost-first shoppers who want a documented choice between compounded and brand GLP-1 pricing in a limited set of states.
Visit Better U CareHarbor
Cost-first shoppers who want price-sensitive shoppers who want a 'locked, no-increase' pricing promise on entry-tier compounded GLP-1s.
Visit HarborThe verdict
Better U Care and Harbor tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Better U Care (ranked #94, a hair above #100) — Cost-first shoppers who want a documented choice between compounded and brand GLP-1 pricing in a limited set of states. But Harbor is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Better U Care.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Better U Care | Harbor |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $298/mo | $99/mo (starting dose, compounded) |
| Tirzepatide / mo | $397/mo | $149/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $3,576 | $1,188 |
| Tirzepatide / yr (modeled) | $4,764 | $1,788 |
| Coverage | 21 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Yes |
| Rank here | #94 | #100 |
Better U Care
69/100Where the value is
- Publishes both compounded and brand-name pricing side by side, letting shoppers compare directly
- Uniform compounded pricing across all doses, with supplies stated as included
- Publishes its actual list of 21 covered states rather than a vague 'most states' claim
The tradeoffs
- Available in 21 states, not nationwide
- It's unclear from the site whether the separately-listed $150 clinical consultation fee is included in or added on top of the $298/$397 compounded prices — needs re-verification
Harbor
69/100Where the value is
- Among the lowest entry-tier prices seen in this set ($99 semaglutide / $149 tirzepatide)
- Explicit 'No Price Increases / Locked pricing' claim, addressing a common bait-and-switch risk
- LegitScript badge verifiably tied to the visitharbor.com domain itself
The tradeoffs
- 'As low as' framing without a visible full pricing/tier page (404'd)
- No individual is designated 'medical director' despite three physicians being pictured
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.